Core Viewpoint - A class action lawsuit has been initiated against LifeMD, Inc. on behalf of investors who purchased the company's securities between May 7, 2025, and August 5, 2025, seeking to recover losses incurred during this period [1][3]. Summary by Sections Lawsuit Details - The lawsuit claims that defendants made materially false and misleading statements regarding LifeMD's competitive position and financial guidance for 2025, failing to account for rising customer acquisition costs in the RexMD segment and related to obesity treatment drugs [3]. Investor Information - Investors who suffered losses have until October 27, 2025, to seek appointment as lead plaintiff and can visit the provided link for more information on eligibility for potential recovery [2]. Law Firm Background - Johnson Fistel, PLLP is a nationally recognized law firm specializing in shareholder rights and securities class action lawsuits, representing both individual and institutional investors [4].
LifeMD, Inc. Shareholders Who Lost Money on Their Investment are Encouraged to Contact Johnson Fistel about the Class Action Lawsuit